Whole Genome Sequencing : A Considered Approach to Clinical Implementation

The recent entry of “whole” exome/“whole” genome sequencing into limited clinical practice has led to a progression of the availability of genome‐scale testing beyond deletion/duplication copy number arrays. This unit provides a considered approach to the implementation of such testing in routine clinical practice. Specifically, we will highlight the challenges in patient selection and consent, and the technical issues surrounding test interpretation and reporting. The unit will then provide practical solutions that allow for genome‐wide sequencing to be implemented in current clinical practice. Curr. Protoc. Hum. Genet. 77:9.22.1‐9.22.7. © 2013 by John Wiley & Sons, Inc.

[1]  D. Bick,et al.  Whole Exome and Whole Genome Sequencing – Community Plan Medical Policy , 2018 .

[2]  I. Tikhonova,et al.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.

[3]  David P Bick,et al.  Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.

[4]  M. Skolnick,et al.  Genetic susceptibility to breast and ovarian cancer. , 1997, Pathologie-biologie.

[5]  A. StAteMent Points to consider in the clinical application of genomic sequencing , 2012, Genetics in Medicine.

[6]  Soma Das,et al.  Technical Standards and Guidelines: Molecular Genetic Testing for Ultra-Rare Disorders , 2005, Genetics in Medicine.

[7]  James P Evans,et al.  Return of results: not that complicated? , 2012, Genetics in Medicine.

[8]  I. Kohane,et al.  Taxonomizing, sizing, and overcoming the incidentalome , 2012, Genetics in Medicine.

[9]  Marylyn D. Ritchie,et al.  Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network , 2012, Genetics in Medicine.

[10]  Shashikant Kulkarni,et al.  Assuring the quality of next-generation sequencing in clinical laboratory practice , 2012, Nature Biotechnology.

[11]  Richard Mayeux,et al.  Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors , 2011, Genetics in Medicine.

[12]  Muin J Khoury,et al.  Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time , 2011, Genetics in Medicine.

[13]  Leslie G. Biesecker,et al.  Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project , 2012, Genetics in Medicine.

[14]  N. Spinner,et al.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. , 2015, American Journal of Human Genetics.

[15]  D. Dimmock A personal perspective on returning secondary results of clinical genome sequencing , 2012, Genome Medicine.

[16]  E. Clayton,et al.  The legal risks of returning results of genomics research , 2012, Genetics in Medicine.

[17]  Stephen C. J. Parker,et al.  Accurate and comprehensive sequencing of personal genomes. , 2011, Genome research.

[18]  D. Dimmock,et al.  Next-generation sequencing facilitates the diagnosis in a child with twinkle mutations causing cholestatic liver failure. , 2012, Journal of pediatric gastroenterology and nutrition.

[19]  W. Grody,et al.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.

[20]  K. Hirschhorn,et al.  Duty to re-contact , 1999, Genetics in medicine : official journal of the American College of Medical Genetics.

[21]  H. Jacob,et al.  A timely arrival for genomic medicine , 2011, Genetics in Medicine.

[22]  Robert C. Green,et al.  Exploring concordance and discordance for return of incidental findings from clinical sequencing , 2012, Genetics in Medicine.

[23]  D. Evans,et al.  Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany , 2011, Journal of Community Genetics.

[24]  T. Klein,et al.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network , 2011, Clinical pharmacology and therapeutics.